The Combination of Oral Anticoagulant and Antiplatelet Therapies: Stay One Step Ahead

F. Luca, S. Giubilato, S.A. Di Fusco, A. Leone, S. Poli, C.M. Rao, A. Iorio, S. Gelsomino, D. Gabrielli, F. Colivicchi, L. De Luca, M.M. Gulizia

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Article number1074248420923528
Pages (from-to)391-398
Number of pages8
JournalJournal of Cardiovascular Pharmacology and Therapeutics
Volume25
Issue number5
DOIs
Publication statusPublished - 1 Sep 2020

Keywords

  • acute coronary syndromes
  • anticoagulant therapy
  • antiplatelet therapy
  • antithrombotic regimen
  • aspirin
  • atrial fibrillation
  • atrial-fibrillation patients
  • coronary artery disease
  • dabigatran
  • doacs
  • double-blind
  • intervention
  • myocardial-infarction
  • rivaroxaban
  • triple therapy
  • DOACs
  • RIVAROXABAN
  • ASPIRIN
  • TRIPLE THERAPY
  • INTERVENTION
  • MYOCARDIAL-INFARCTION
  • ACUTE CORONARY SYNDROMES
  • ATRIAL-FIBRILLATION PATIENTS
  • DABIGATRAN
  • DOUBLE-BLIND
  • ANTITHROMBOTIC REGIMEN

Cite this